The drugmaker Pfizer Thursday agreed to suspend sales of painkiller Bextra after regulators found risk of serious side effects. Health correspondent Susan Dentzer discusses the Food and Drug ...

The fate of a highly controversial class of painkillers is likely to be decided at a federal inquiry scheduled to open later this week. FDA documents show that the hearings will focus on evidence that ...

The "information" document filed by federal prosecutors against Mary Holloway describes what appears to be a rogue sales unit inside Pfizer dedicated to selling the painkiller Bextra off-label and at ...

Critics say millions of people were needlessly exposed to the risks of Bextra due to intense off-label promotion and advertising that boosted the painkiller to a position near the top of the list of ...

The fate of a highly controversial class of painkillers is likely to be decided at a federal inquiry scheduled to open Wednesday. In three days of hearings, the FDA and a panel of outside experts will ...

Pfizer takes drug Bextra off marketAs Pfizer Inc. removed the painkiller Bextra from the market yesterday under pressure from the FDA, the government said almost all of the nation’s popular ...